| Celeste L Hernandez-morales, RN | |
|
228 Lafayette St, Newark, NJ 07105-1815 | |
| (973) 220-6354 | |
| Not Available |
| Full Name | Celeste L Hernandez-morales |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 228 Lafayette St, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801653878 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR14725900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Celeste L Hernandez-morales, RN 825 Ridge St, Newark, NJ 07104-2325 Ph: (973) 873-5222 | Celeste L Hernandez-morales, RN 228 Lafayette St, Newark, NJ 07105-1815 Ph: (973) 220-6354 |
News Archive
Hemispherx Biopharma, Inc. announced that the Company has entered into an agreement with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA for the marketing of Alferon N Injection®, the Company's natural interferon injection product which has been FDA approved for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries upon receipt of those respective countries' regulatory approval for any use of the product.
Black breast cancer patients have shorter survival than white breast cancer patients largely because of a higher rate of other disorders, such as diabetes and hypertension, according to a study in the October 12 issue of JAMA: The Journal of the American Medical Association.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
A Mayo Clinic-led study has revealed a genetic biomarker that can predict which patients are most likely to experience unwanted side effects from one of the most commonly used and highly effective chemotherapy regimens designed to treat colorectal cancer.
The partnership between ABC News and MedPage Today entered a new phase with the November 1 premiere of "Doctor's Orders," a featured series on Good Morning America Weekend.
› Verified 7 days ago
Mrs. Ariane Monique Chua Dequina, MSN, RN, NP-C, CMSRN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 340 Airis Drive, Newark, NJ 07114 Phone: 973-877-0991 | |
Dr. Nancy S Redeker, PH.D., R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen St Rm 1122, Umdnj School Of Nursing, Newark, NJ 07107 Phone: 973-972-3875 Fax: 973-972-7853 | |
Paul V Scott, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5043 | |
Miriam Salami, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 687 S 17th St, Fl 1, Newark, NJ 07103 Phone: 973-444-5487 | |
Ms. Jessica Hampson, RN, RNFA, CNOR Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 | |
Vasley St.juste, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 75 Sandford Pl, Newark, NJ 07106 Phone: 973-288-3474 | |
Mr. Eduardo Jamisola Padilla Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 515 Mount Prospect Ave Apt 17b, Newark, NJ 07104 Phone: 201-724-5582 |